source
- MacroGenics sells manufacturing operations to Bora for $122.5M; West Pharma reports cybersecurity breachMacroGenics announced it is selling its clinical and commercial drug substance manufacturing portfolio to CDMO Bora. The deal includes an upfront payment of $122.5 million. The transaction transfe…
- Understanding MET Alterations in Non‑Small Cell Lung Cancer and Emerging Targeted Treatment OptionsThe article outlines the primary MET alterations observed in non‑small cell lung cancer, focusing on gene amplification and exon 14 skipping mutations. It explains that these MET changes frequentl…